Clinical Trial Update: A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 pediatric trial aims to identify the highest tolerated dose of a cedazuridine-decitabine combination with filgrastim after hematopoietic stem cell tra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Cedazuridine (Cedazuridine)
• Decitabine (Decitabine)
• Filgrastim (filgrastim)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Acute Myeloid Leukemia Post Cytotoxic Therapy, Recurrent Acute Myeloid Leukemia | Phase 1 | Status: NOT_YET_RECRUITING